194 related articles for article (PubMed ID: 31564640)
1. Re: Rohann J.M. Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2019.06.002.
Montorsi F; Larcher A; Capitanio U
Eur Urol Focus; 2021 Mar; 7(2):406. PubMed ID: 31564640
[No Abstract] [Full Text] [Related]
2. Reply to Francesco Montorsi, Alessandro Larcher, and Umberto Capitanio's Letter to the Editor re: Rohann J.M. Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Eur Urol Focus. 2019 Jun 24. pii: S2405-4569(19)30157-9. https://doi.org/10.1016/j.euf.2019.06.002. [Epub ahead of print].
Correa RJM; Louie AV; Zaorsky NG; Lehrer EJ; Ellis R; Ponsky L; Kaplan I; Mahadevan A; Chu W; Swaminath A; Hannan R; Onishi H; Teh BS; Muacevic A; Lo SS; Staehler M; Siva S
Eur Urol Focus; 2021 Mar; 7(2):404-405. PubMed ID: 31679868
[No Abstract] [Full Text] [Related]
3. Re: Julia Dagnæs-Hansen, Gitte Hjartbro Kristensen, Hein V. Stroomberg, Søren Schwartz Sørensen, Martin Andreas Røder. Surgical Approaches and Outcomes in Living Donor Nephrectomy: A Systematic Review and Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.03.021.
Pecoraro A; Li Marzi V; Serni S; Campi R
Eur Urol Focus; 2023 Jan; 9(1):216-217. PubMed ID: 35798648
[No Abstract] [Full Text] [Related]
4. Re: Bimal Bhindi, Jeffrey Graham, J. Connor Wells, et al. Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.038: Cytoreductive Nephrectomy: To Whom and When?
Mollica V; Rizzo A; Massari F
Eur Urol Oncol; 2020 Aug; 3(4):559-560. PubMed ID: 32553708
[No Abstract] [Full Text] [Related]
5. Re: Börje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.006.
Wei Y; Zhang R; Lin L
Eur Urol; 2022 Sep; 82(3):e88. PubMed ID: 35750581
[No Abstract] [Full Text] [Related]
6. Re: Andrea Mari, Riccardo Tellini, Francesco Porpiglia, et al. Perioperative and Mid-term Oncological and Functional Outcomes After Partial Nephrectomy for Complex (PADUA Score ≥10) Renal Tumors: A Prospective Multicenter Observational Study (the RECORD2 Project). Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.07.004.
Grivas N; Goonewardene S; Everaerts W; Kalampokis N;
Eur Urol Focus; 2021 Sep; 7(5):1210-1211. PubMed ID: 33358885
[No Abstract] [Full Text] [Related]
7. Re: Ragheed Saoud, Varat Woranisarakul, Gladell P. Paner, et al. Physician Perception of Grade Group 1 Prostate Cancer. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.04.002.
Gandaglia G; Barletta F; Briganti A; Montorsi F
Eur Urol Focus; 2024 Jan; 10(1):205. PubMed ID: 37455217
[No Abstract] [Full Text] [Related]
8. Editorial Comment: The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Zequi SC
Int Braz J Urol; 2020; 46(3):473. PubMed ID: 32167721
[No Abstract] [Full Text] [Related]
9. Reply to Alessio Pecoraro, Vincenzo Li Marzi, Sergio Serni, and Riccardo Campi's Letter to the Editor re: Julia Dagnæs-Hansen, Gitte Hjartbro Kristensen, Hein V. Stroomberg, Søren Schwartz Sørensen, Martin Andreas Røder. Surgical Approaches and Outcomes in Living Donor Nephrectomy: A Systematic Review and Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.03.021.
Dagnæs-Hansen J; Hjartbro Kristensen G; Stroomberg HV; Schwartz Sørensen S; Røder MA
Eur Urol Focus; 2023 Jan; 9(1):218. PubMed ID: 35803853
[No Abstract] [Full Text] [Related]
10. Stereotactic ablative radiotherapy for primary kidney cancer.
Brown N; Breen DJ; Buckley BT; Clements W; Gangi A; Rogan C
Lancet Oncol; 2024 Jun; 25(6):e229. PubMed ID: 38821090
[No Abstract] [Full Text] [Related]
11. Stereotactic ablative radiotherapy for primary kidney cancer.
Bhargava P; Jena R; Giri RK
Lancet Oncol; 2024 Jun; 25(6):e228. PubMed ID: 38821089
[No Abstract] [Full Text] [Related]
12. Stereotactic Ablative Body Radiotherapy: An Emerging Weapon in the Treatment Armamentarium for Renal Cell Carcinoma or a Potential Avenue for Overtreatment?
Magee DE; Wong JK; Correa AF
Eur Urol; 2022 Dec; 82(6):623-624. PubMed ID: 35945083
[No Abstract] [Full Text] [Related]
13. Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCK.
Correa RJM; Louie AV; Staehler M; Warner A; Gandhidasan S; Ponsky L; Ellis R; Kaplan I; Mahadevan A; Chu W; Swaminath A; Onishi H; Teh BS; Lo SS; Muacevic A; Siva S
J Urol; 2019 Jun; 201(6):1097-1104. PubMed ID: 30741849
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic ablative radiotherapy for primary kidney cancer - Authors' reply.
Siva S; Moon D; Pryor D
Lancet Oncol; 2024 Jun; 25(6):e230. PubMed ID: 38821091
[No Abstract] [Full Text] [Related]
15. Re: Sarah R. Ottenhof, Andrew Leone, Rosa S. Djajadiningrat, et al. Surgical and Oncological Outcomes in Patients After Vascularized Flap Reconstruction for Locoregionally Advanced Penile Cancer. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2018.02.002.
Innocenti A; Melita D; Ghezzi S
Eur Urol Focus; 2019 Nov; 5(6):1157. PubMed ID: 29674120
[No Abstract] [Full Text] [Related]
16. Re: Yash S. Khandwala, Simon John Christoph Soerensen, Shravan Morisetty, et al. The Association of Tissue Change and Treatment Success During High-intensity Focused Ultrasound Focal Therapy for Prostate Cancer. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.10.010.
Gravina C; Lombardo R; De Nunzio C
Eur Urol Focus; 2023 Sep; 9(5):851-852. PubMed ID: 37005167
[No Abstract] [Full Text] [Related]
17. Reply to Nikolaos Grivas, Sanchia Goonewardene, Wouter Everaerts, Nikolaos Kalampokis's Letter to the Editor re: Andrea Mari, Riccardo Tellini, Francesco Porpiglia, et al. Perioperative and Mid-term Oncological and Functional Outcomes After Partial Nephrectomy for Complex (PADUA Score ≥10) Renal Tumors: A Prospective Multicenter Observational Study (the RECORD2, Project). Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.07.004.
Mari A; Tellini R; Ficarra V; Carini M; Minervini A;
Eur Urol Focus; 2021 Sep; 7(5):1212-1213. PubMed ID: 33384273
[No Abstract] [Full Text] [Related]
18. Re: Philipp Mandel, Benedikt Hoeh, Mike Wenzel, et al. Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.08.007.
Gandaglia G; Briganti A; Raggi D; Marandino L; Necchi A; Di Maio M; Montorsi F
Eur Urol Focus; 2023 Feb; ():. PubMed ID: 36813620
[No Abstract] [Full Text] [Related]
19. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Correa RJM; Louie AV; Zaorsky NG; Lehrer EJ; Ellis R; Ponsky L; Kaplan I; Mahadevan A; Chu W; Swaminath A; Hannan R; Onishi H; Teh BS; Muacevic A; Lo SS; Staehler M; Siva S
Eur Urol Focus; 2019 Nov; 5(6):958-969. PubMed ID: 31248849
[TBL] [Abstract][Full Text] [Related]
20. Re: Georges Mjaess, Alexandre Peltier, Jean-Baptiste Roche, et al. A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging-Targeted and Systematic Biopsies: A European Multicenter Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.04.008.
Gravina C; Lombardo R; De Nunzio C
Eur Urol Focus; 2024 Jan; 10(1):206-207. PubMed ID: 37541916
[No Abstract] [Full Text] [Related]
[Next] [New Search]
